Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells.

CONCLUSIONS: circFoxp1 is an oncogene in EOC cells and can confer DDP resistance to EOC cells. Circulating exosomal circFoxp1 can be used as a biomarker and potential therapeutic target for EOC.
PMID: 32808501 [PubMed - in process]

Source: Journal of Gynecologic Oncology - August 20, 2020 Category: OBGYN Tags: J Gynecol Oncol Source Type: research